Friday, October 30, 2026

Report: North Korea Leveraging IT to Tighten State Economic Control

North Korea is enhancing economic control through IT, with a shift in management policies and a focus on centralized state guidance.

North Korea’s Military Strategy: What the 9th Party Congress Means for Regional Security

North Korea is advancing its nuclear and conventional military capabilities, raising concerns of an arms race and prompting South Korea to refine its strategy.

AACR 2026 Highlighted Shift Toward Patient-Centered Cancer Drug Development, Foundation Says

Cancer research is evolving towards patient-centered outcomes, integrating data and technology for better treatments, as noted at AACR 2026.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

OSCA vs. Placebo: How Stem Cell Treatment for Knee Pain is Changing Lives

Kangstem Biotech accelerates follow-up clinical trials and global technology transfer after securing final results of knee osteoarthritis stem cell therapy.

Brazil’s Biopharmaceutical Boom: How Samsung and Celltrion Are Capitalizing on the Biosimilars Market

Brazil is becoming a key overseas market for biosimilar companies due to its large pharmaceutical market and government support.

How Boryung’s Partnership with DLR is Revolutionizing Space Life Science Research in 2026

Boryung partners with the German Aerospace Center to secure potential clients for space life science research infrastructure.

Exploring AI Healthcare: How SEERS Expands Wearable Tech in Vietnam and Kazakhstan

Wearable AI medical company SEERS expands overseas to Vietnam and Kazakhstan, focusing on ECG solutions and AI smart ward systems.

Discover Why Dermagram PDRN Cream is the Must-Have K-Beauty Product for Foreign Tourists in Korea

Chong Kun Dang's PDRN cream is recommended for foreign tourists on Korea Tourism Organization's official portal.

Robot-Assisted Surgery Removes Uterine Fibroids Up to 11 Centimeters While Preserving Fertility

A surgeon at Soonchunhyang University Bucheon Hospital used robot-assisted surgery to remove large, multiple uterine fibroids from three women in their 30s and 40s who planned to become pregnant, preserving their uteruses.

Dong-A ST Sees Potential for Topical Formulation of Psoriasis Drug Icotrokinra

Dong-A ST reported preclinical findings suggesting that icotrokinra, an oral treatment for psoriasis, could be developed into a topical formulation that delivers the drug through the skin and reduces inflammation.

Samsung Bioepis Confirms Pharmacokinetic Equivalence in Phase 1 Trial of Keytruda Biosimilar

Samsung Bioepis reported that its Keytruda biosimilar candidate SB27 demonstrated pharmacokinetic equivalence to the original drug in a Phase 1 trial, supporting its continued development as a potential lower-cost immunotherapy for cancer patients.

Hanmi Pharmaceutical’s Weight-Loss Drug Epe Expected to Become Available for Prescriptions on Oct. 29

Hanmi Pharmaceutical’s obesity treatment Epe is expected to become available at some medical institutions on Oct. 29, with its relatively low initial supply price potentially improving access as nationwide distribution ramps up.

Ilsan CHA Hospital Reaches 20,000 Deliveries, With High-Risk Births Accounting for More Than Half

Ilsan CHA Hospital has recorded 20,000 deliveries since opening its maternity services in January 2020, with more than half involving high-risk pregnancies, highlighting its role in providing specialized maternal and newborn care in northern Gyeonggi Province.

XERF: The Revolutionary High-Frequency Medical Device Expanding in Europe and North America

Cynosure Lutronic is expanding the global market for its high-frequency medical device XERF through conferences for healthcare professionals.

Unlocking the U.S. Market: How South Korean Medical Device Companies Can Succeed with STAMPED Program

The Korea Health Industry Development Institute partners with Texas Medical Center to support domestic health companies entering the U.S. market.

Revolutionary Gene Therapy for Gitelman Syndrome: How Korean Researchers are Restoring Kidney Function

Researchers confirmed that inserting normal genes into cells of patients with Gitelman syndrome restores sodium transport function.

Revolutionary Antiviral Jepti Unveiled at IDWeek 2026: What It Means for Dengue and Similar Viruses

Hyundai BioScience's antiviral candidate Jepti (CP-COV03) was presented at the major U.S. infectious disease conference IDWeek 2026.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.